Clovis Oncology, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boulder, CO
SEC filing record 1 source field available
Fiscal year end
31 December
Clovis Oncology, Inc. has filed 952 SEC EDGAR filings since 25 Jun 2009

SEC filing history

Showing 676-700 of 951 matching filings.

Per page
25
Current page
28
4

PRIMARY DOCUMENT

Filing date
15 Jun 2015
Reporting date
11 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Jun 2015
Reporting date
01 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
18 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86488

CLOVIS

Filing date
18 May 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 May 2015
Reporting date
13 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 May 2015
Reporting date
14 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
06 May 2015
Reporting date
06 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 May 2015
Reporting date
01 May 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-35347

DEFA14A

Filing date
30 Apr 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-35347

DEFINITIVE PROXY STATEMENT

Filing date
30 Apr 2015
Reporting date
11 Jun 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Apr 2015
Reporting date
01 Apr 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
11 Mar 2015
Reporting date
09 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-86488

SC 13D/A FOR CLOVIS ONCOLOGY, INC. BY DOMAIN PARTNERS VII

Filing date
10 Mar 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Mar 2015
Reporting date
05 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Mar 2015
Reporting date
03 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
04 Mar 2015
Reporting date
02 Mar 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35347

CLOVIS ONCOLOGY, INC. 8-K

Filing date
25 Feb 2015
Reporting date
25 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Feb 2015
Reporting date
17 Feb 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-86488

13G/A

Filing date
18 Feb 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .